Ticker Details
iCAD, Inc. Common Stock icad Inc is a provider of image analysis, work flow solutions and radiation therapy for early identification and treatment of cancer. The company has cancer detection and cancer therapy segments.
IPO Date:	December 1, 1984
Sector:	Healthcare
Industry:	Health Care Technology
Market Cap:	$102.74M
Activated in VL:	False

Average Daily Range
Avg Daily Range:	$0.14 | 3.28%
Avg Daily Range (30 D):	$0.07 | 1.87%
Avg Daily Range (90 D):	$0.07 | 2.17%

Institutional Daily Volume
Avg Daily Volume:	.14M
Avg Daily Volume (30 D):	.06M
Avg Daily Volume (90 D):	.54M

Trade Size
Avg Trade Size (Sh.):	215
Avg Trade Size (Sh.) (30 D):	172
Avg Trade Size (Sh.) (90 D):	219

Institutional Trades
Total Institutional Trades:	56
Avg Institutional Trade:	$1.6M
Avg Institutional Trade (30 D):	$1.52M
Avg Institutional Trade (90 D):	$1.04M
Avg Institutional Trade Volume:	.18M
Avg Institutional Trades (Per Day):	1

Market Closing Trades
Avg Closing Trade:	$3.73M
Avg Closing Trade (30 D):	$M
Avg Closing Trade (90 D):	$M
Avg Closing Volume:	463.07K

News

Jun 15, 2025 @ 7:51 PM SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Invest... Source: N/A

Jun 15, 2025 @ 6:29 PM HAPPY FATHER’S DAY and $HARHOLDER ALERT: Th... Source: Monteverde & Associates Pc

Jun 10, 2025 @ 6:25 AM $TOCKHOLDER ALERT: The M&A Class Action Firm Encou... Source: Prnewswire

May 21, 2025 @ 10:00 PM $HAREHOLDER ALERT: The M&A Class Action Firm Urges... Source: Monteverde & Associates Pc

May 13, 2025 @ 3:28 PM Behind the FDA's AI Push: A Growing Class of Publi... Source: Prnewswire

Financials
	TTM	Q1 2025	Q4 2024
Basic EPS	$-.2	$-.03	$-.03
Diluted EPS
Revenue	$19.53M	$4.87M	$5.41M
Gross Profit	$16.71M	$4.19M	$4.67M
Net Income / Loss	$-5.23M	$-.83M	$-.85M
Operating Income / Loss	$-5.96M	$-1.13M	$-.87M
Cost of Revenue	$2.82M	$.69M	$.74M
Net Cash Flow	$2.83M	$2.83M	$M
PE Ratio